Engineers Gate Manager LP Rigel Pharmaceuticals Inc Transaction History

Engineers Gate Manager LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$1.07 - $1.39 $107 - $139	-100 Reduced 0.97%	10,162 $10,000
Q1 2023 May 15, 2023	BUY	$1.25 - $2.0 $125 - $200	100 Added 0.98%	10,262 $13,000
Q4 2022 Feb 14, 2023	BUY	$0.67 - $11.9 $6,808 - $120,927	10,162 New	10,162 $15,000
Q2 2022 Aug 15, 2022	SELL	$0.67 - $3.19 $23,127 - $110,115	-34,519 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.22 - $3.45 $76,632 - $119,090	34,519 New	34,519 $103,000
Q4 2017 Feb 01, 2018	SELL	$3.23 - $4.3 $101,531 - $135,166	-31,434 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$2.18 - $2.57 $68,526 - $80,785	31,434	31,434 $80,000

334K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.96B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.